UBS O'Connor’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,175,766
Closed -$464M 862
2021
Q4
$464M Buy
+5,175,766
New +$439M 4.47% 5
2017
Q1
Sell
-68,109
Closed -$3.05M 504
2016
Q4
$3.05M Buy
68,109
+15,917
+30% +$705K 0.06% 269
2016
Q3
$2.48M Buy
+52,192
New +$2.7M 0.04% 290
2016
Q2
Sell
-10,275
Closed -$469K 540
2016
Q1
$469K Sell
10,275
-19,725
-66% -$754K 0.01% 366
2015
Q4
$1.12M Sell
30,000
-20,000
-40% -$707K 0.02% 300
2015
Q3
$1.63M Buy
+50,000
New +$1.59M 0.03% 311
2015
Q2
Sell
-14,905
Closed -$464K 925
2015
Q1
$464K Hold
14,905
0.01% 516
2014
Q4
$411K Buy
+14,905
New +$391K 0.01% 465

Other funds holding CONE

UBS O'Connor's CONE Position: Q1 2022 in Review

UBS O'Connor sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 5,175,766 shares — an estimated $464M sold.

UBS O'Connor first reported a position in CONE in Q4 2014 and held it in 8 quarters. The position peaked at $464M in Q4 2021. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

  • UBS O'Connor reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
  • UBS O'Connor sold 5,175,766 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $464M.
  • UBS O'Connor first reported a position in CyrusOne Inc Common Stock in Q4 2014 and held it in 8 quarters.
  • UBS O'Connor's CyrusOne Inc Common Stock position peaked at $464M in Q4 2021.
  • 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.